Cancer in the Faroe Islands from 1960-2019 – incidence, mortality, and comparisons with the other Nordic countries

References

• Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020-2070. Nat Rev Clin Oncol. 2021;18(10):663–672.
   PubMed Web of Science ®Google Scholar
• Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747–755.
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods part II. Completeness. Eur J Cancer. 2009;45(5):756–764.
   PubMed Web of Science ®Google Scholar
• Føroya H. Population | Statistics Faroe Islands. [cited 2022 March 31]. https://hagstova.fo/en/population/population/population.
   Google Scholar
• Nomesco Editorial Group. Health statistics for the Nordic Countries. 2017, Copenhagen; 2017.
   Google Scholar
• Landslaeknin, Health report from the Chief Medical Officer in the Faroe Islands2020; 2021. [cited 2022 March 31]. https://landslaeknin.stps.dk/fo/tiindi/heilsulysing-landslaeknans-fyri-2020#.
   Google Scholar
• Honnudóttir V, Hansen L, Veyhe AS, et al. Social inequality in type 2 diabetes mellitus in the Faroe Islands: a cross-sectional study. Scand J Public Health. 2021;014034948211013268:140349482110132.
   Web of Science ®Google Scholar
• Karlsdóttir A, Heleniak T, Kull M. Births, children and young people. In: State of the Nordic Region; 2020. Chapter 2; p. 28–38.
   Google Scholar
• Gregersen NO, Lescai F, Liang J, et al. Whole-exome sequencing implicates DGKH as a risk gene for panic disorder in the Faroese Population. Am J Med Genet B Neuropsychiatr Genet. 2016;171(8):1013–1022.
   PubMed Web of Science ®Google Scholar
• Johansen M, Svenstrup K, Joensen P, et al. High incidence of amyotrophic lateral sclerosis in the Faroe Islands 2010-2020. Ann Clin Transl Neurol. 2022;9(2):227–231.
   PubMed Web of Science ®Google Scholar
• Petersen MS, Guella I, Bech S, et al. Parkinson's disease, genetic variability and the Faroe Islands. Parkinsonism Relat Disord. 2015;21(1):75–78.
   PubMed Web of Science ®Google Scholar
• Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37(2):215–222.
   PubMed Web of Science ®Google Scholar
• Hammer T, Nielsen KR, Munkholm P, et al. The Faroese IBD study: Incidence of inflammatory bowel diseases across 54 years of population-based data. J Crohns Colitis. 2016;10(8):934–942.
   PubMed Web of Science ®Google Scholar
• Maret-Ouda J, Tao W, Wahlin K, et al. Nordic registry-based cohort studies: possibilities and pitfalls when combining Nordic Registry Data. Scand J Public Health. 2017;45(17_suppl):14–19.
   PubMed Web of Science ®Google Scholar
• F.I. Ministry of Health, Cancerplan for the Faroe Islands; 2022. [cited 2022 April 26]. https://lms.cdn.fo/media/16479/132865-heilsumálaráðið-bók-krabbameinsaetlan.pdf?s=oH4B7wkoxbhfRX5U0ANyH4cctHY.
   Google Scholar
• Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-a national Danish project. Health Policy. 2012;105(1):65–70.
   PubMed Web of Science ®Google Scholar
• Dalberg J, Jacobsen Ó, Storm HH, et al. Cancerregistrering på faerøerne. Ugeskr Laeger. 1998;160:3058–3062.
   PubMedGoogle Scholar
• Olsen SH, Friborg J, Ellefsen B, et al. Incidence and survival of head and neck cancer in the Faroe Islands. Int J Circumpolar Health. 2021;80(1):1894697.
   PubMed Web of Science ®Google Scholar
• Engholm G, Ferlay J, Christensen N, et al. NORDCAN-a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010;49(5):725–736.
   PubMed Web of Science ®Google Scholar
• Larønningen S, Ferlay J, Bray F, et al. Nordcan 2.0. [cited 2022 March 22]. Available from: https://nordcan.iarc.fr/en.
   Google Scholar
• Ursin G, Bentzen HB. Open science and sharing personal data widely – legally impossible for Europeans? Acta Oncol. 2021;60(12):1555–1556.
   PubMed Web of Science ®Google Scholar
• Storm HH. Data may save lives – cancer epidemiology needed to guide public health and clinical progress. Acta Oncol. 2020;59(11):1263–1265.
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Greenland S, Lash T. Modern epidemiology. 3rd edition. Lippincott Williams & Wilkins: Philadelphia (PA); 2008.
   Google Scholar
• Boccellino M, Vanacore D, Zappavigna S, et al. Testicular cancer from diagnosis to epigenetic factors. Oncotarget. 2017;8(61):104654–104663.
   PubMedGoogle Scholar
• Gaddam SJ, Chesnut GT. Testicle cancer. StatPearls Publishing LLC: Treasure Island (FL); 2021.
   Google Scholar
• Garner MJ, Turner MC, Ghadirian P, et al. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116(3):331–339.
   PubMed Web of Science ®Google Scholar
• Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ. 2000;321(7264):789–792.
   PubMed Web of Science ®Google Scholar
• Garolla A, Vitagliano A, Muscianisi F, et al. Role of viral infections in testicular cancer etiology: evidence from a systematic review and meta-analysis. Front Endocrinol. 2019;10:355.
   PubMed Web of Science ®Google Scholar
• Halling J, Petersen MS, Jørgensen N, et al. Semen quality and reproductive hormones in Faroese men: a cross-sectional population-based study of 481 men. BMJ Open. 2013;3(3):e001946.
   PubMed Web of Science ®Google Scholar
• Mol NM, Sorensen N, Weihe P, et al. Spermaturia and serum hormone concentrations at the age of puberty in boys prenatally exposed to polychlorinated biphenyls. Eur J Endocrinol. 2002;146(3):357–363.
   PubMed Web of Science ®Google Scholar
• Virtanen HE, Toppari J. Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update. 2008;14(1):49–58.
   PubMed Web of Science ®Google Scholar
• McGlynn KA, Quraishi SM, Graubard BI, et al. Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res. 2009;69(5):1901–1909.
   PubMed Web of Science ®Google Scholar
• Steenland K, Winquist A. PFAS and cancer, a scoping review of the epidemiologic evidence. Environ Res. 2021;194:110690.
   PubMed Web of Science ®Google Scholar
• Weihe P, Joensen HD. Dietary recommendations regarding pilot whale meat and blubber in the Faroe Islands. Int J Circumpolar Health. 2012;71:18594.
   PubMed Web of Science ®Google Scholar
• Longnecker MP, Wolff MS, Gladen BC, et al. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect. 2003;111(1):65–70.
   PubMed Web of Science ®Google Scholar
• Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer. 2019;11:151–164.
   PubMed Web of Science ®Google Scholar
• Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology. 2001;12:68–73.
   PubMed Web of Science ®Google Scholar
• Clemmensen SB, Harris JR, Mengel-From J, et al. Familial risk and heritability of hematologic malignancies in the nordic twin study of cancer. Cancers. 2021;13(12):3023.
   PubMed Web of Science ®Google Scholar
• Jønsson V, Awan H, Jones ND, et al. Inheritance of susceptibility to malignant blood disorders. Sci Rep. 2019;9(1):2444.
   PubMed Web of Science ®Google Scholar
• Conforti C, Zalaudek I. Epidemiology and risk factors of melanoma: a review. Dermatol Pract Concept. 2021;11(Suppl 1):e2021161S.
   PubMedGoogle Scholar
• Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–89.
   PubMedGoogle Scholar